Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

61 résultats
Page :
triés par

Necrotizing colitis during neuroleptic treatment

 Clément Roux , Hélène Peyrière , Jean-Luc Faillie , F. Garcia , Dominique Hillaire-Buys , et al.
11ème congrés annuel de la société française de pharmacologie, 74ème congrès annuel de la société de physiologie, 11-13 Avril 2007, Toulouse, France, 2007, Toulouse, France
Communication dans un congrès hal-03074391v1
Image document

Case–non-case studies: Principle, methods, bias and interpretation

 Jean-Luc Faillie
Alternative and Complementary Therapies, 2019, 74 (2), pp.225-232. ⟨10.1016/j.therap.2019.01.006⟩
Article dans une revue hal-02887324v1
Image document

La découverte des sulfamides hypoglycémiants à Montpellier en 1942

 Thierry Lavabre-Bertrand , Jean-Luc Faillie
Thérapie, 2021, 76 (6), pp.559-566. ⟨10.1016/j.therap.2021.09.003⟩
Article dans une revue hal-03624634v1
Image document

Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study

 Jérémy T Campillo , Céline Eiden , Michel Boussinesq , Sébastien Pion , Jean-Luc Faillie , et al.
British Journal of Clinical Pharmacology, 2022, 88 (3), pp.1094-1106. ⟨10.1111/bcp.15037⟩
Article dans une revue hal-03853323v1
Image document

Adverse reactions related to brentuximab vedotin use: A real-life retrospective study

 B. Clarivet , L. Vincent , L. Vergely , V. Bres , K. Foglia , et al.
Thérapie, 2019, 74 (3), pp.343-346. ⟨10.1016/j.therap.2018.07.004⟩
Article dans une revue hal-02555942v1
Image document

Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database.

 Jean-Luc Faillie , Samy Babai , Sabrina Crépin , Virginie Bres , Marie-Laure Laroche , et al.
Acta Diabetologica, 2013, 51 (3), pp.491-497. ⟨10.1007/s00592-013-0544-0⟩
Article dans une revue hal-00922480v1

Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study

 Clement Mathieu , Elodie Pambrun , Anne Benard-Laribiere , Pernelle Noize , Jean-Luc Faillie , et al.
European Journal of Epidemiology, 2022, 37 (10), pp.1049-1059. ⟨10.1007/s10654-022-00912-2⟩
Article dans une revue hal-03836387v1

REPRISCAR–Suivi des patients ayant fait une toxidermie sévère entre 2009 et 2019 : impact sur la prise ultérieure de traitements et sur la qualité de vie

 J. Litovsky , A. Gauthier , D. Hillaire-Buys , C. Philibert , J. Bourrain , et al.
Revue francaise d'allergologie, 2021, 61 (4), pp.277. ⟨10.1016/j.reval.2021.03.119⟩
Article dans une revue hal-03676039v1
Image document

Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series

 Cyrille Coustal , Juliette Vanoverschelde , Xavier Quantin , Candice Lesage , Jean-Marie Michot , et al.
Journal for Immunotherapy of Cancer, 2023, 11 (5), pp.e004792. ⟨10.1136/jitc-2022-004792⟩
Article dans une revue hal-04116183v1

Indication bias or protopathic bias?

 Jean-Luc Faillie
British Journal of Clinical Pharmacology, 2015, 80 (4), pp.779-780. ⟨10.1111/bcp.12705⟩
Article dans une revue hal-01983159v1
Image document

Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study

 Laurine Diaz , Benjamin Jauzelon , Anne-Charlotte Dillies , Cosette Le Souder , Jean-Luc Faillie , et al.
Journal of Clinical Medicine, 2023, 12, ⟨10.3390/jcm12051985⟩
Article dans une revue hal-04143194v1

Nicorandil-induced ulcerations: a 10-year observational study of all cases spontaneously reported to the French pharmacovigilance network.

 Valérie Babic , Nadine Petitpain , Claire Guy , Philippe Trechot , Anne-Claire Bursztejn , et al.
International Wound Journal, 2018, 15 (4), pp.508-518. ⟨10.1111/iwj.12845⟩
Article dans une revue hal-02322300v1

Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution

 Pierre Rocanières , Sylvain Lamure , Christian Geny , Dominique Hillaire-Buys , Jean-Luc Faillie , et al.
Letter, 2022, pp.2601-2603. ⟨10.3233/JPD-223496⟩
Autre publication scientifique hal-04142920v1

Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases

 Quentin Dardonville , Esther Salguiero , Vanessa Rousseau , Leila Chebane , Jean Luc Faillie , et al.
European Journal of Clinical Pharmacology, 2019, 75 (12), pp.1705-1711. ⟨10.1007/s00228-019-02743-9⟩
Article dans une revue hal-02563133v1
Image document

Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes

 Jean-Luc Faillie , Hui Yin , Oriana Yu , Astrid Herrero , Romain Altwegg , et al.
Clinical Pharmacology and Therapeutics, 2022, 111 (1), pp.272-282. ⟨10.1002/cpt.2430⟩
Article dans une revue hal-03853682v1

Reply to letter to the editor: hypoglycemia and treatment with opioids

 Basile Chretien , Charles Dolladille , Léa Hamel-Sénécal , Marion Sassier , Jean Luc Faillie , et al.
Expert Opinion on Drug Safety, 2019, 18 (12), pp.1265-1266. ⟨10.1080/14740338.2019.1673364⟩
Article dans une revue hal-02559269v1

Comparative study of hypoglycaemia induced by opioids. Is it a class effect?

 Basile Chretien , Charles Dolladille , Léa Hamel-Sénécal , Marion Sassier , Jean Luc Faillie , et al.
Expert Opinion on Drug Safety, 2019, 18 (10), pp.987-992. ⟨10.1080/14740338.2019.1646246⟩
Article dans une revue hal-02572474v1
Image document

Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials

 Carole Piera-Mardemootoo , Philippe Lambert , Jean-Luc Faillie
Thérapie, 2021, 76 (6), pp.647-656. ⟨10.1016/j.therap.2018.01.006⟩
Article dans une revue hal-02341129v1
Image document

Incretin-based drugs and intestinal obstruction: A pharmacovigilance study

 Bastien Gudin , Chayma Ladhari , Perrine Robin , Marie-Laure Laroche , Samy Babai , et al.
Thérapie, 2020, 75 (6), pp.641 - 647. ⟨10.1016/j.therap.2020.02.024⟩
Article dans une revue hal-03493460v1

Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!

 Dominique Hillaire-Buys , Jean-Luc Faillie , Jean-Louis Montastruc , Pierre Petit
European Journal of Clinical Pharmacology, 2012, epub ahead of print. ⟨10.1007/s00228-012-1299-1⟩
Article dans une revue istex hal-00706826v1
Image document

Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue

 Jean-Luc Faillie , Dominique Hillaire-Buys
Pharmacoepidemiology and Drug Safety, 2016, 25 (2), pp.212 - 214. ⟨10.1002/pds.3925⟩
Article dans une revue istex hal-01886850v1
Image document

Scientific evidence and controversies about pioglitazone and bladder cancer: which lessons can be drawn?

 Jean-Luc Faillie , Pierre Petit , Jean-Louis Montastruc , Dominique Hillaire-Buys
Drug Safety, 2013, 36 (9), pp.693-707. ⟨10.1007/s40264-013-0086-y⟩
Article dans une revue hal-03633017v1
Image document

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

 Devin Abrahami , Antonios Douros , Hui Yin , Oriana Hy Yu , Jean-Luc Faillie , et al.
BMJ, 2018, 363, pp.k4880. ⟨10.1136/bmj.k4880⟩
Article dans une revue hal-02309224v1

Serious adverse drug reactions with sacubitril/valsartan Entresto(R): a French pharmacovigilance survey

 F. Moulis , V. Rousseau , L. Chebane , Amandine Gouverneur , L. Gaboriau , et al.
European Journal of Clinical Pharmacology, 2018, 74 (7), pp.983-984. ⟨10.1007/s00228-018-2460-2⟩
Article dans une revue hal-03193827v1
Image document

Diabetes and COVID-19

 Béatrice Bouhanick , Jean-Luc Cracowski , Jean-Luc Faillie
Thérapie, 2020, 75 (4), pp.327-333. ⟨10.1016/j.therap.2020.05.006⟩
Article dans une revue hal-03580195v1
Image document

SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database

 Abdel Nasser Ado Moumouni , Perrine Robin , Dominique Hillaire-Buys , Jean-Luc Faillie
Fundamental & Clinical Pharmacology, 2017, ⟨10.1111/fcp.12334⟩
Article dans une revue hal-01742114v1

DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus

 Antoine Pariente , Vanessa Labat , Yohann Mansiaux , Francesco Salvo , Bernard Begaud , et al.
Drug Safety, In press, 43 (8), pp.767-774. ⟨10.1007/s40264-020-00936-1⟩
Article dans une revue hal-03136382v1
Image document

Le biais de temps immortel dans les études pharmacoépidémiologiques : définition, solutions et exemples

 Jean-Luc Faillie , Samy Suissa
Thérapie, 2015, 70 (3), pp.259-263. ⟨10.2515/therapie/2014207⟩
Article dans une revue istex hal-02157541v1

Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials

 M. Rehman , B.V. Tudrej , J. Soustre , M. Buisson , P. Archambault , et al.
Diabetes & Metabolism, 2017, 43 (1), pp.48 - 58. ⟨10.1016/j.diabet.2016.09.005⟩
Article dans une revue hal-01808205v1
Image document

Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics

 Michiel J. Bakkum , Jelle Tichelaar , Paraskevi Papaioannidou , Robert Likic , Emilio J. Sanz Alvarez , et al.
British Journal of Clinical Pharmacology, 2021, 87 (3), pp.1001-1011. ⟨10.1111/bcp.14453⟩
Article dans une revue hal-03597430v1
Page :